| Ticker: MIMS | One Blue Hill Plaza | |
| Exchange: NASDAQ-National Market | Pearl River, New York 10965 | |
| Industry: Service | (914) 735-3555 |
| Type of Shares: | Common Shares | Filing Date: | 6/6/96 | |
| U.S. Shares: | 4,000,000 | Offer Date: | 8/14/96 | |
| Non-U.S. Shares: | 0 | Filing Range: | $14.00 - $16.00 | |
| Primary Shares: | 4,000,000 | Offer Price: | $13.00 | |
| Secondary Shares: | 0 | Gross Spread: | $0.91 | |
| Offering Amount: | $60,000,000 | Selling: | $0.50 | |
| Expenses: | $1,000,000 | Reallowance: | $0.10 | |
| Shares Out After: | 12,023,800 |
| Manager | Tier | Phone |
| PaineWebber Incorporated | Lead Manager | (212) 713-2626 |
| Dillon, Read & Co. Inc. | Co-manager | (212) 906-7000 |
| Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 12/31/95 | 3/31/96 | 3/31/95 | 3/31/96 | ||
| Revenue: | $213.93 | $66.59 | $29.20 | Assets: | $20.48 |
| Net Income: | -$6.77 | -$0.29 | -$0.52 | Liabilities: | $32.26 |
| EPS: | -$1.43 | -$0.04 | -$0.12 | Equity: | -$11.78 |
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year | |||||
| Business Description |
| The company is a pharmacy management organization that provides a broad range of services designed to promote the cost-effective delivery of pharmacy benefits. The company targets organizations involved in three key segments of the pharmaceutical health care industry--sponsors of public and private health plans, retail pharmacies and pharmaceutical manufacturers--and offers services that provide financial benefits to each of them. The company works with plan sponsors and local health care professionals to design, implement and manage innovative programs to control pharmacy benefit costs, primarily through financial risk sharing arrangements and increased substitution of lower-cost generic drugs for brand name drugs. Participating retail pharmacies receive management and support services, as well as financial incentives to purchase and dispense preferred generic drugs. Finally, the company offers manufacturers of generic drugs the potential to increase their market share in regions covered by participating pharmacies as a result of the increase in generic drug utilization encouraged by the company's programs. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used to expand preferred generics business; to fund additional pharmacy benefit management programs; enhance its management information systems capabilities; and for general corporate purposes. |
©1996 IPO Data Systems, Inc. - All rights reserved.